about
N-acetylcysteine improves established monocrotaline-induced pulmonary hypertension in ratsDasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension.A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents.Emerging molecular targets for anti-proliferative strategies in pulmonary arterial hypertension.Pathogenesis of pulmonary arterial hypertension: lessons from cancer.Immune dysregulation and endothelial dysfunction in pulmonary arterial hypertension: a complex interplay.Leptin signalling system as a target for pulmonary arterial hypertension therapy.New molecular targets of pulmonary vascular remodeling in pulmonary arterial hypertension: importance of endothelial communication.New targets for pulmonary arterial hypertension: going beyond the currently targeted three pathways.Pulmonary hemodynamic responses to inhaled NO in chronic heart failure depend on PDE5 G(-1142)T polymorphism.Renal Denervation Reduces Pulmonary Vascular Remodeling and Right Ventricular Diastolic Stiffness in Experimental Pulmonary Hypertension.Dichloroacetate treatment partially regresses established pulmonary hypertension in mice with SM22alpha-targeted overexpression of the serotonin transporter.Role for interleukin-6 in COPD-related pulmonary hypertension.Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension.Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.A genome-wide association analysis identifies PDE1A|DNAJC10 locus on chromosome 2 associated with idiopathic pulmonary arterial hypertension in a Japanese population.Role of Stromelysin 2 (Matrix Metalloproteinase 10) as a Novel Mediator of Vascular Remodeling Underlying Pulmonary Hypertension Associated With Systemic Sclerosis.Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertension.Proinflammatory Signature of the Dysfunctional Endothelium in Pulmonary Hypertension. Role of the Macrophage Migration Inhibitory Factor/CD74 Complex.Dasatinib increases endothelial permeability leading to pleural effusion.Role of Nerve Growth Factor in Development and Persistence of Experimental Pulmonary Hypertension.Regulatory T Cell Dysfunction in Idiopathic, Heritable and Connective Tissue-Associated Pulmonary Arterial Hypertension.Design, Synthesis, and Biological Activity of New N-(Phenylmethyl)-benzoxazol-2-thiones as Macrophage Migration Inhibitory Factor (MIF) Antagonists: Efficacies in Experimental Pulmonary Hypertension.Delayed Microvascular Shear Adaptation in Pulmonary Arterial Hypertension. Role of Platelet Endothelial Cell Adhesion Molecule-1 Cleavage.[Towards new targets for the treatment of pulmonary arterial hypertension : Importance of cell-cell communications].Angiomatoid fibrous histiocytoma of the pulmonary artery: a multidisciplinary discussion.Switching-Off Adora2b in Vascular Smooth Muscle Cells Halts the Development of Pulmonary Hypertension.T-cell costimulation blockade is effective in experimental digestive and lung tissue fibrosisNintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertensionEctopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertensionRight lung ischemia induces contralateral pulmonary vasculopathy in an animal modelRole of Endothelium-derived CC Chemokine Ligand 2 in Idiopathic Pulmonary Arterial HypertensionTransgenic Mice Overexpressing the 5-Hydroxytryptamine Transporter Gene in Smooth Muscle Develop Pulmonary HypertensionMacrophage Migration Inhibitory Factor (MIF) Inhibition in a Murine Model of Bleomycin-Induced Pulmonary Fibrosis[New insights in the pathogenesis of pulmonary arterial hypertension]Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary HypertensionResponse by Guignabert et al to Letter Regarding Article, "Selective BMP-9 Inhibition Partially Protects Against Experimental Pulmonary Hypertension"Prevention of progression of pulmonary hypertension by the Nur77 agonist 6-mercaptopurine: role of BMP signallingChronic inflammation within the vascular wall in pulmonary arterial hypertension: more than a spectatorConnexin-43 is a promising target for pulmonary hypertension due to hypoxaemic lung disease
P50
Q33786092-EFD5D1A0-9971-4ACF-B05E-92E7EDF314DFQ37217507-5E6F9F53-866B-4891-A8C8-A7C793B8E4A4Q37410202-78BB69AA-5E69-4C7F-970D-6C7C61F87E45Q38149040-8243777F-5317-41F2-9950-07D05E7F19F2Q38167729-568270D7-D01B-4EA7-A68B-371A4685D6D0Q38198974-E310F315-205B-4DF6-897A-B5332E4416A8Q38300615-2BAE4339-61A0-4412-B7EF-8CB786372F0DQ38341718-4DFC177A-548A-4AD8-807F-4FB0C57E3982Q38674676-6CBE4FD9-3CDD-4B03-85C6-7C79A395C703Q39385171-0D26A0B9-CBC1-497C-B053-7DBE9699A476Q42370379-B1665EF4-0A79-43D9-9341-69825373833DQ43292319-F54ABD0E-2B27-457D-870E-E2439CDF8F31Q45893801-71E9C815-691D-4691-AADA-A4E8D39C7CB3Q46617580-5E11A621-B4D2-4B68-A7C2-19E1855FBD46Q47372748-810EED62-F251-4E92-ADAB-5310E99CF2D8Q47581804-A4A6003A-4F22-4973-8174-AB86707A15D0Q47957345-FCC9154F-7DFF-4490-99AE-E6EEBBF7CDABQ47962632-A7F1BFC1-4FD0-4A63-B0A6-18866675EE54Q48155147-FF425721-55EF-4777-B21B-C9C2DD0D61C4Q48216756-4F7DF215-4811-408C-B6E5-B076F46368E6Q50969268-43DFEE42-06AA-4AA2-A204-D72670BD37C2Q51550351-43A1AEF9-3C1B-45CA-ABD4-E2A9DE204339Q52662257-5553CFF1-356B-4A74-BFBC-3ED1BAA25E40Q52889395-8F580F6A-C0DD-4798-9647-6E6A8E96791EQ53767909-FD7D24B6-9760-4CE0-BB5E-5F2F744FF812Q54214606-041BD2E6-227F-45EA-85FF-A418EA081F9AQ55259961-B5125DAC-C3D0-4654-8A36-1F1CD8CCFDDFQ58273913-B087B5A5-3D21-4B33-94F9-2A75CCE691B7Q58273922-4D3C7279-9733-4A52-934B-6E28CE260D79Q58273930-FEFB1A1C-7424-4EAB-BAB0-C23B51B5C0C7Q58274091-091EFE46-7F4D-4279-ABE4-42D0B551347CQ58274166-B4B0059B-2C0A-4309-B0ED-DF80B5009A42Q58274173-C5302F10-8160-49C0-AC55-722F9225EC35Q60950058-697143D1-FE95-47AA-99E1-4CB07215EF91Q90211948-BF18D248-B28D-4114-8F7E-4D14756C8922Q91017242-0318E15C-C18A-4BCB-90B1-8BD08A27D88DQ91506715-27EC23AD-C919-41A6-85D7-0E1FB984E8F9Q91620684-0A9B4920-707B-4B17-9C61-F8A5EDB2CE9CQ91783071-CB194352-7C69-430B-B431-93D7FF996799Q92161951-1968C771-98F1-43B3-BE34-B74A789B2A7F
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ly Tu
@ast
Ly Tu
@en
Ly Tu
@es
Ly Tu
@nl
type
label
Ly Tu
@ast
Ly Tu
@en
Ly Tu
@es
Ly Tu
@nl
prefLabel
Ly Tu
@ast
Ly Tu
@en
Ly Tu
@es
Ly Tu
@nl
P106
P1153
23006846000
P31
P496
0000-0003-2336-5099